See more : Artius Acquisition Inc. (AACQU) Income Statement Analysis – Financial Results
Complete financial analysis of Entourage Health Corp. (ENTG.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Entourage Health Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- LAMF Global Ventures Corp. I (LGVCW) Income Statement Analysis – Financial Results
- Sino-i Technology Limited (SNOIF) Income Statement Analysis – Financial Results
- Technip Energies N.V. (THNPY) Income Statement Analysis – Financial Results
- BGI Genomics Co., Ltd. (300676.SZ) Income Statement Analysis – Financial Results
- Haverty Furniture Companies, Inc. (HVT-A) Income Statement Analysis – Financial Results
Entourage Health Corp. (ENTG.V)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://entouragehealthcorp.com
About Entourage Health Corp.
Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. The company offers cannabis plants, dried cannabis, oils, topicals, extracts, and edibles. It provides its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinals, and Mary's Medicinals brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.71M | 40.89M | 42.27M | 29.43M | 20.82M | 7.96M | 1.45M | 353.18K | 0.00 | 0.00 |
| Cost of Revenue | 37.01M | 60.78M | 53.99M | 53.64M | 5.95M | 3.32M | 1.20M | 176.59K | 0.00 | 0.00 |
| Gross Profit | 3.71M | -19.89M | -11.71M | -24.21M | 14.87M | 4.63M | 249.90K | 176.59K | 0.00 | 0.00 |
| Gross Profit Ratio | 9.11% | -48.64% | -27.71% | -82.24% | 71.43% | 58.25% | 17.22% | 50.00% | 0.00% | 0.00% |
| Research & Development | 179.00 | 201.61K | 396.96K | 834.42K | 54.76K | 138.95K | 67.46K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.71M | 24.10M | 25.73M | 26.71M | 16.41M | 13.69M | 6.97M | 98.40K | 32.78K | 130.82K |
| Selling & Marketing | 5.42M | 5.54M | 3.46M | 1.77M | 4.65M | 1.23M | 412.64K | 0.00 | 45.81K | 61.40K |
| SG&A | 25.13M | 29.64M | 29.19M | 28.48M | 21.06M | 14.92M | 7.38M | 98.40K | 32.78K | 130.82K |
| Other Expenses | -21.43M | 59.74K | 5.96M | 3.98M | -144.15K | 448.89K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.71M | 32.14M | 30.02M | 27.25M | 21.38M | 14.97M | 7.47M | 98.40K | 32.78K | 130.82K |
| Cost & Expenses | 62.49M | 92.92M | 84.01M | 80.89M | 27.33M | 18.29M | 8.67M | 98.40K | 32.78K | 130.82K |
| Interest Income | 0.00 | 0.00 | 10.77M | 65.76K | 222.16K | 513.28K | 73.24K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 24.39M | 17.19M | 0.00 | 5.91M | 1.24M | 442.13K | 1.65M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 384.09K | 5.85M | 6.75M | 2.15M | 279.56K | 104.34K | 366.10K | 165.03K | 12.09K | 5.52K |
| EBITDA | -21.40M | -99.83M | -61.29M | -81.55M | -8.87M | -348.66K | -6.78M | -98.40K | -1.76M | -3.09M |
| EBITDA Ratio | -52.56% | -113.44% | -68.94% | -153.77% | -29.54% | -116.53% | -467.51% | -27.86% | 0.00% | 0.00% |
| Operating Income | -21.38M | -52.24M | -35.89M | -47.41M | -6.43M | -9.37M | -7.15M | -98.40K | -32.78K | -130.82K |
| Operating Income Ratio | -52.51% | -127.75% | -84.91% | -161.08% | -30.89% | -117.84% | -492.74% | -27.86% | 0.00% | 0.00% |
| Total Other Income/Expenses | -24.79M | -71.64M | -37.20M | -38.15M | -2.03M | 9.44M | -1.66M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -46.17M | -123.15M | -78.94M | -89.61M | -10.39M | -895.13K | -8.81M | -98.40K | -32.78K | -130.82K |
| Income Before Tax Ratio | -113.40% | -301.15% | -186.73% | -304.43% | -49.91% | -11.25% | -606.81% | -27.86% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 17.25M | 16.73M | 9.89M | 1.10M | 891.02K | 1.65M | -613.23K | -824.03K | 72.35K |
| Net Income | -46.17M | -123.15M | -78.94M | -89.61M | -10.39M | -895.13K | -8.81M | -98.40K | -32.78K | -130.82K |
| Net Income Ratio | -113.40% | -301.15% | -186.73% | -304.43% | -49.91% | -11.25% | -606.81% | -27.86% | 0.00% | 0.00% |
| EPS | -0.15 | -0.40 | -0.32 | -0.43 | -0.09 | -0.01 | -0.15 | -0.10 | -0.03 | -0.07 |
| EPS Diluted | -0.15 | -0.40 | -0.32 | -0.43 | -0.09 | -0.01 | -0.15 | -0.10 | -0.03 | -0.07 |
| Weighted Avg Shares Out | 307.85M | 305.06M | 249.01M | 208.05M | 116.09M | 104.63M | 57.11M | 1.03M | 1.02M | 1.85M |
| Weighted Avg Shares Out (Dil) | 307.85M | 305.06M | 249.01M | 208.05M | 116.09M | 106.48M | 57.11M | 1.03M | 1.02M | 1.85M |
Source: https://incomestatements.info
Category: Stock Reports